Drug intelligence / Profile preview

99mTc-P137

Development stage
Preclinical
Lead developer
Sun Yat-sen University
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

99mTc-P137 is a technetium-99m labeled radiopharmaceutical designed for the diagnostic imaging of prostate cancer via Single Photon Emission Computed Tomography (SPECT/CT). The agent is a molecular probe that specifically targets the Prostate-Specific Membrane Antigen (PSMA), a transmembrane protein that is highly overexpressed in prostate malignant tissues compared to normal tissues. By binding to PSMA, 99mTc-P137 allows for the visualization of primary prostate tumors and metastatic lesions. This tracer is being investigated as a potentially more accessible and cost-effective alternative to PET-based PSMA tracers (such as 68Ga-PSMA-11) due to the widespread availability of Technetium-99m generators and SPECT/CT equipment in clinical settings.

Other names
technetium Tc 99m P137Tc-99m-P137Tc99m-P137Tc 99m-P137
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on 99mTc-P137.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 99mTc-P137.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call